.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Chubb
Cerilliant
UBS
Johnson and Johnson
Dow
AstraZeneca
Express Scripts
Healthtrust

Generated: December 18, 2017

DrugPatentWatch Database Preview

Mayne Pharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for MAYNE PHARMA INC, and what generic and branded alternatives to MAYNE PHARMA INC drugs are available?

MAYNE PHARMA INC has seventeen approved drugs.



Summary for Mayne Pharma Inc

US Patents:0
Tradenames:15
Ingredients:15
NDAs:17
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma IncOXYCODONE HYDROCHLORIDEoxycodone hydrochlorideTABLET;ORAL091313-003Feb 18, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma IncAMIODARONE HYDROCHLORIDEamiodarone hydrochlorideTABLET;ORAL075389-001Jan 25, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma IncDOXYCYCLINE HYCLATEdoxycycline hyclateTABLET;ORAL208765-002Jun 14, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma IncOXYCODONE AND ACETAMINOPHENacetaminophen; oxycodone hydrochlorideTABLET;ORAL090177-006Oct 20, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma IncNYSTATINnystatinPOWDER;TOPICAL065203-001Jul 15, 2004ATRXNoYes► Subscribe► Subscribe► Subscribe
Mayne Pharma IncOXYCODONE HYDROCHLORIDEoxycodone hydrochlorideTABLET;ORAL091313-002Feb 18, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma IncDOFETILIDEdofetilideCAPSULE;ORAL207058-001Jun 6, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma IncDOFETILIDEdofetilideCAPSULE;ORAL207058-002Jun 6, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma IncMORPHINE SULFATEmorphine sulfateTABLET, EXTENDED RELEASE;ORAL205386-002Oct 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma IncMORPHINE SULFATEmorphine sulfateTABLET, EXTENDED RELEASE;ORAL205386-003Oct 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Healthtrust
Citi
Covington
Cantor Fitzgerald
Queensland Health
US Army
Federal Trade Commission
Fuji
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot